21 Dec Concept to Cure: Latest Breakthroughs in Metastatic Breast Cancer
Wed., Feb. 28th, 2018 | 7:30 a.m.- 12:00 p.m. | Sanford Consortium for Regenerative Medicine
Join Susan G. Komen® San Diego and our partners, Bank of America and Salk Women & Science for our first annual Metastatic Breast Cancer Conference – Concept to Cure. The conference, will be held on February 28th, 2018 at the Sanford Consortium for Regenerative Medicine from 7:30 to noon and will bring together leading experts in the metastatic breast cancer research field with researchers, medical professionals and representatives from local area pharmaceutical and biotech companies. Featuring presentations by Dr. Jay Desgrosellier of UC San Diego, Dr. Barbara Parker, Medical Director at UC San Diego Moores Cancer Center and Dr. Geoff Wahl of the Salk Institute.
If you are a biomedical researcher, medical professional, pharmaceutical or biotechnology representative or you’re simply interested in learning about the latest in metastatic breast cancer research we encourage you to attend.
This event is FREE however space is limited, please RSVP to let us know you will be attending.
JAY DESGROSELLIER, Ph.D.
Assistant Professor, UC San Diego Deptartment of Pathology
and Susan G. Komen Funded Researcher
Dr. Desgrosellier will share a new therapeutic approach that could stop breast cancer metastasis from forming and spreading—rare stem-like tumor cells play a critical role in the spread of breast cancer, but a vulnerability in the pathway that powers them offers a strategy to target these cells using existing drugs before metastatic disease occurs.
BARBARA PARKER, M.D.
Senior Deputy Director, Cancer Medicine Medical Director, Oncology Services,
Prof. of Medicine, Division of Hematology/Oncology
UC San Diego Moores Cancer Center
Dr. Parker will discuss the “Personalized Approaches to Prevent and Treat Advanced Breast Cancer.” Her presentation will cover: Clinical challenges of tumor heterogeneity – subtypes and unique mutational profiles (“snowflakes”); personalized approaches to screening and prevention; the best way to cure cancer is to prevent it, progress in using the neoadjuvant setting to determine novel drug activity and molecular Tumor Boards and personalized targeted therapy.
GEOFFREY M. WAHL, Ph.D.
Salk Institute (NCI)-designated basic research cancer center
Professor, Gene Expression
Laboratory, Adjunct Professor at UCSD and Komen Scholar.
Dr. Wahl will present a brief overview of metastasis and its complexities. Wahl will also present on intratumoral heterogeneity and how it arises. Lastly he will discuss how tumor cells can reprogram to a very plastic state which, by the action of one transcription factor that is regulated by paracrine factors such as FGF, can reversibly produce motile, invasive cells that acquire a neural crest like state from transformed mammary cells.
NEW Breakthrough therapeutic approach that could stop breast cancer metastasis from forming
Integration of research and clinical practice
Importance of clinical trials
February 28, 2018 - 7:30 am
92037 Show map